Zobrazeno 1 - 10 of 517 pro vyhledávání: '"Roland B, Walter"'
2
Akademický článek
Efficient long-term multilineage engraftment of CD33-edited hematopoietic stem/progenitor cells in nonhuman primates
Autor: Nicholas E. Petty, Stefan Radtke, Emily Fields, Olivier Humbert, Mallory J. Llewellyn, George S. Laszlo, Haiying Zhu, Keith R. Jerome, Roland B. Walter, Hans-Peter Kiem
Publikováno v: Molecular Therapy: Methods & Clinical Development, Vol 31, Iss , Pp 101121- (2023)
Current immunotherapeutic targets are often shared between neoplastic and normal hematopoietic stem and progenitor cells (HSPCs), leading to unwanted on-target, off-tumor toxicities. Deletion or modification of such targets to protect normal HSPCs is
Externí odkaz: https://doaj.org/article/bbf076d5311d4ffc9cd892e144be7ab2
Zobrazit plný text záznamu
3
Akademický článek
The present and future of measurable residual disease testing in acute myeloid leukemia
Autor: James S. Blachly, Roland B. Walter, Christopher S. Hourigan
Publikováno v: Haematologica, Vol 107, Iss 12 (2022)
Considerable progress has been made in the past several years in the scientific understanding of, and available treatments for, acute myeloid leukemia (AML). Achievement of a conventional remission, evaluated cytomorphologically via small bone marrow
Externí odkaz: https://doaj.org/article/337eb01baade4d8d87dfc8f07b993f9d
Zobrazit plný text záznamu
5
Akademický článek
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia
Autor: Corentin Orvain, Jacob A. Wilson, Min Fang, Brenda M. Sandmaier, Eduardo Rodríguez-Arbolí, Brent L. Wood, Megan Othus, Frederick R. Appelbaum, Roland B. Walter
Publikováno v: Haematologica, Vol 108, Iss 2 (2022)
Measurable residual disease (MRD) before hematopoietic cell transplantation (HCT) is an independent established prognostic factor in patients with acute myeloid leukemia (AML). Several methods exist to evaluate the presence of residual leukemia cells
Externí odkaz: https://doaj.org/article/17202d83bbe0411cbe3f0805e3769126
Zobrazit plný text záznamu
7
Akademický článek
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party
Autor: Jesse M. Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Wolfgang Kern, Roland B. Walter, Brent L. Wood, Christophe Roumier, Jan Philippé, Barbara Denys, Jeffrey L. Jorgensen, Marie C. Bene, Francis Lacombe, Adriana Plesa, Monica L. Guzman, Agnieszka Wierzbowska, Anna Czyz, Lok Lam Ngai, Adrian Schwarzer, Costa Bachas, Jacqueline Cloos, Marion Subklewe, Michaela Fuering-Buske, Francesco Buccisano
Publikováno v: HemaSphere, Vol 6, Iss 1, p e676 (2022)
Measurable residual disease (MRD) quantified by multiparameter flow cytometry (MFC) is a strong and independent prognostic factor in acute myeloid leukemia (AML). However, several technical factors may affect the final read-out of the assay. Experts
Externí odkaz: https://doaj.org/article/58aecfe07be0436ea3d70c88f7d1c3d5
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje